Myelodysplastic syndrome (MDS) refers to a group of blood cancers that cause your body to make abnormal blood cells. These cells can crowd out normal ones, leaving you with low blood cell counts.
Myelodysplastic syndromes (MDS), also known as myelodysplastic neoplasms, are conditions that can occur when the blood-forming cells in the bone marrow become abnormal, resulting in the marrow not making enough healthy new blood cells.
Myelodysplastic syndrome (MDS) is a type of cancer in which the bone marrow does not produce healthy cells. Find out here about the outlook and life expectancy for a person with MDS.
Many individuals with myelodysplastic syndrome (MDS) have no noticeable symptoms when diagnosed. The condition is often first found after blood testing shows low blood cell counts. Anemia, caused by a lack of red blood cells, is the most common symptom in MDS.
The myelodysplastic syndromes (MDS) are group of clonal hematopoietic stem cell abnormalities typified by peripheral cytopenia, dysplastic hematopoietic progenitors, a hypercellular or hypocellular bone marrow, and a high risk of conversion to acute myeloid leukemia.
Myelodysplastic syndromes (MDS) treatment options include supportive care, drug therapy, and chemotherapy with allogeneic stem cell transplant. Learn more about newly diagnosed or recurrent MDS and its treatment in this expert-reviewed summary.
Myelodysplastic syndromes (MDS) are an often unrecognized, under-diagnosed, rare group of bone marrow failure disorders, where the body no longer makes enough healthy, normal blood cells in the bone marrow. The disease is also recognized as a form of blood cancer.
With MDS, your bone marrow cells become abnormal and make blood cells that don’t grow or work like normal cells. They also die earlier than normal cells. You might sometimes hear it called a...